research paper - 700-1000 words
please provide resources
Canadian biotechnology firm's entry strategy in the EuropeanUnion market
A small Canadian firm that has developed some valuable newmedical products using its unique biotechnology know-how is tryingto decide how best to serve the European Union. Its choices aregiven below. The cost of investment in manufacturing facilitieswill be a major one for the Canadian firm, but it is not outsideits reach. If these are the firm’s only options, which one wouldyou advise it to choose? Why?
(i) Manufacture the product at home and let foreign sales agentshandle marketing.